title: Cross-desensitization between angiotensin II and endothelin-1 in the pithed rat.
abstract: It has been shown that in vitro angiotensin II (Ang II) potently downregulates endothelin-1 (ET-1) binding sites. In this study, we investigated in vivo the interactions between the renin-angiotensin system and ET-1. Sprague-Dawley rats were pithed, ventilated, and diastolic blood pressure (DBP) was recorded. ET-1 (1 nmol/kg) induced a biphasic response: a transient hypotension followed by a sustained increase of DBP. Captopril (5 mg/kg, i.v.) or Sar1-Ile8-Ang II (10 ng/kg/min) did not affect ET-1 responses. In other experiments, DBP was increased by infusion of methoxamine (MTX: 10, 20, 25, 32.5 micrograms/kg/min) or Ang II (50, 100, 150, 200 ng/kg/min). ET-1-induced hypotension correlated with the level of DBP (r = 0.94) for both agonists. The elevation of DBP in response to ET-1 was also related to the vascular tone but was dose-dependently attenuated by Ang II infusion when compared with MTX. Conversely, infusion of ET-1 (0.1 nmol/kg/min) blunted the pressor response to Ang II (0.1 micrograms/kg) but not to MTX (50 micrograms/kg). These doses induced the same increase of DBP in pithed control rats. Similarly, increased plasma renin activity induced by chronic salt depletion (0% NaCl) in pithed rats provoked a shift to the right of the dose-response curves to Ang II and ET-1 but not to MTX. These results suggest an in vivo cross-desensitization between ET-1 and Ang II.
authors.affiliation: Institut Henri Beaufour Research Laboratories, Les Ulis, France.
authors.forename: J M
authors.initials: JM
authors.lastname: Guillon
authors.forename: E
authors.initials: E
authors.lastname: Etiemble
authors.forename: P
authors.initials: P
authors.lastname: Roubert
authors.forename: M
authors.initials: M
authors.lastname: Auguet
authors.forename: P E
authors.initials: PE
authors.lastname: Chabrier
authors.forename: P
authors.initials: P
authors.lastname: Braquet
mesh_terms: D015059:1-Sarcosine-8-Isoleucine Angiotensin II / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001381:Azepines / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D002216:Captopril / Q000494:pharmacology; D003655:Decerebrate State; D015259:Dopamine Agents / Q000494:pharmacology; D016232:Endothelins / Q000494:pharmacology*; D008297:Male; D008729:Methoxamine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012083:Renin / Q000097:blood
chemical_list: D001381:Azepines; D015259:Dopamine Agents; D016232:Endothelins; D000804:Angiotensin II; C024763:talipexole; D015059:1-Sarcosine-8-Isoleucine Angiotensin II; D002216:Captopril; D012083:Renin; D008729:Methoxamine